Ticker Scorecard - CRDF Basics Company: Cardiff Oncology, Inc. IPO Date: August 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $250.13M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.23% Avg Daily Range (30 D): $0.21 | 4.92% Avg Daily Range (90 D): $0.19 | 5.00% Institutional Daily Volume Avg Daily Volume: .85M Avg Daily Volume (30 D): 1M Avg Daily Volume (90 D): 1.59M Trade Size Avg Trade Size (Sh.): 172 Avg Trade Size (Sh.) (30 D): 133 Avg Trade Size (Sh.) (90 D): 156 Institutional Trades Total Inst.Trades: 170 Avg Inst. Trade: $2.02M Avg Inst. Trade (30 D): $.56M Avg Inst. Trade (90 D): $1.05M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.09M Avg Closing Trade (30 D): $.56M Avg Closing Trade (90 D): $.8M Avg Closing Volume: 349.53K     News Mar 8, 2025 @ 12:33 PM Why the Global Cancer Market Could Surpass $900 Bi... Source: Prnewswire Dec 10, 2024 @ 12:20 PM Cardiff Oncology Prices Oversubscribed $40 Million... Source: Globe Newswire Dec 10, 2024 @ 11:00 AM Cardiff Oncology Announces Positive Initial Data f... Source: N/A May 29, 2024 @ 8:05 PM Cardiff Oncology to Present at the Jefferies Healt... Source: Cardiff Oncology, Inc. May 13, 2024 @ 8:05 PM Cardiff Oncology to Present at Upcoming Investor C... Source: Cardiff Oncology, Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.25 $-.26 $-.22 Diluted EPS $-.25 $-.26 $-.22 Revenue $ .17M $ .16M $ .21M Gross Profit $ $ $ Net Income / Loss $ -11.86M $ -11.78M $ -10.01M Operating Income / Loss $ -12.6M $ -12.55M $ -10.93M Cost of Revenue $ $ $ Net Cash Flow $ -12.46M $ 6.84M $ -3M PE Ratio     Splits Feb 20, 2019:   6:1 Jun 04, 2018:   12:1 May 30, 2012:   6:1